Fenofibrate and Metformin Fixed Combination vs Metformin - FAME METFO
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
To demonstrate in patients with T2DM and dyslipidemia not appropriately controlled with a
statin and receiving metformin, the superiority of a fixed combination of fenofibrate and
metformin vs metformin alone on TG and additionally, if the superiority on TG is established,
to demonstrate the superiority on HDL-C